Trigonelline induces browning in 3T3-L1 white adipocytes

Area of Science:

• Metabolic research
• Cell biology
• Pharmacology

Background:

• Fenugreek alkaloid trigonelline exhibits antidiabetic and anticancer properties.
• Obesity is a growing health concern requiring novel therapeutic strategies.
• Understanding mechanisms of fat metabolism is crucial for developing anti-obesity treatments.

Purpose of the Study:

• To investigate trigonelline's potential as an anti-obesity agent.
• To examine trigonelline's effects on lipid catabolism and adipocyte browning.
• To elucidate the molecular pathways involved in trigonelline's action.

Main Methods:

• Utilized 3T3-L1 white adipocytes to study trigonelline's effects.
• Assessed gene and protein expression related to brown fat and lipid metabolism.
• Investigated signaling pathways including β3-AR, PDE4, and MAPK/ATF-2.

Main Results:

• Trigonelline induced browning in white adipocytes by upregulating key brown-fat signature genes.
• Trigonelline improved lipid metabolism by reducing adipogenesis and lipogenesis, and increasing lipolysis and fatty acid oxidation.
• Trigonelline enhanced mitochondrial biogenesis through increased expression of related genes.
• Mechanistically, trigonelline's browning effect was mediated by β3-AR activation and PDE4 inhibition, activating the p38 MAPK/ATF-2 pathway.

Conclusions:

• Trigonelline demonstrates significant potential as an anti-obesity compound.
• Its ability to induce browning and enhance lipid catabolism in adipocytes supports its therapeutic application.
• High bioavailability in humans further supports its consideration for anti-obesity strategies.